Elisabeth Rosenthal

Whatever Happened to Biden鈥檚 Public Option?

蘑菇影院 Health News Original

In the 2020 elections, then-candidate Joe Biden and many of his congressional colleagues loudly advocated for a federal 鈥減ublic option鈥 health insurance plan. It was framed, at the time, as part of his incoming administration鈥檚 response to the pandemic. 鈥淟ow-income Americans will be automatically enrolled in the public option at zero cost to them, though […]

This State Isn鈥檛 Waiting for Biden To Negotiate Drug Prices

蘑菇影院 Health News Original

As the federal government negotiates with drugmakers to lower the price of 10 expensive drugs for Medicare patients, impatient legislators in some states are trying to go even further. Leading the pack is Colorado, where a new Prescription Drug Affordability Review Board is set to recommend an 鈥渦pper payment limit鈥 for drugs it deems unaffordable. In late […]

How Your In-Network Health Coverage Can Vanish Before You Know It

蘑菇影院 Health News Original

One of the most unfair aspects of medical insurance is this: Patients can change insurance only during end-of-year enrollment periods or at the time of 鈥渜ualifying life events.鈥 But insurers鈥 contracts with doctors, hospitals, and pharmaceutical companies can change abruptly at any time.

The No Surprises Act Comes With Some Surprises

蘑菇影院 Health News Original

The No Surprises Act, the landmark law intended to protect patients from surprise out-of-network medical bills, has come with, well, some surprises. A little more than two years after it took effect, there鈥檚 good and bad news about how it鈥檚 working. First, it鈥檚 important to note that the law has successfully protected millions of patients […]

The FTC Escalates Biden鈥檚 Fight Against Drug Prices

蘑菇影院 Health News Original

It鈥檚 daggers out at the Federal Trade Commission in its fight against anticompetitive practices in health care. This past year, it has issued more stringent guidelines to block and discourage hospital mergers, and it investigated practices by middlemen in the drug supply chain. Now drug manufacturers themselves are in the agency鈥檚 crosshairs. In November, the FTC challenged the validity of more […]

Denials of Health Insurance Claims Are Rising 鈥 And Getting Weirder

蘑菇影院 Health News Original

The Department of Health and Human Services is tasked with monitoring denials both by Obamacare health plans and those offered through employers and insurers. As insurers鈥 denials become more common, they sometimes defy not just medical standards of care but sheer logic. Why hasn鈥檛 the agency fulfilled its assignment?